Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J UOEH ; 41(2): 231-237, 2019.
Artículo en Japonés | MEDLINE | ID: mdl-31292369

RESUMEN

We had a forensic autopsy case in which drugs were detected in a cadaver that had been stored in a cold and wet condition for 5 years. The skin of the cadaver was hard, and the color was partly whitish or dark brown. Though the cadaver had transformed into adipocere in the wet and cold condition, QuEChERS extraction and LC-MS/MS revealed the presence of sulpiride and estazolam in the femoral muscle and bone marrow. The concentrations of sulpiride and estazolam in the femoral muscle were 10.6 ng/g and 39.9 ng/g, respectively. The result of a drug screening test led not only to the cause of death but also to the personal identification of the cadaver. The individual had a history of drug taking, which had been stored in his medical records at the hospital for a long time. The fact of taking sulpiride and estazolam at the same time was characteristic, and it was useful in identifying the cadaver in this case. The progress in analytical technology has made possible the detection of particle drugs from old or adipoceratous cadavers, but there have been no reports of particle drugs being detected in a cadaver that had been dead for 5 years and had transformed to adipocere, as in our present case. The analytical results by LC-MS/MS were certainly important for the diagnosis of the cause of death, and, moreover, they were useful for the purpose of personal identification.


Asunto(s)
Ansiolíticos/análisis , Antipsicóticos/análisis , Autopsia , Cadáver , Cromatografía Liquida/métodos , Estazolam/análisis , Medicina Legal/métodos , Cambios Post Mortem , Sulpirida/análisis , Espectrometría de Masas en Tándem/métodos , Ansiolíticos/aislamiento & purificación , Antipsicóticos/aislamiento & purificación , Estazolam/aislamiento & purificación , Humanos , Masculino , Músculo Esquelético/química , Sulpirida/aislamiento & purificación , Factores de Tiempo
2.
J Hazard Mater ; 320: 204-215, 2016 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-27544733

RESUMEN

This study examines the transformation and removal of the atypical antipsychotics amisulpride and sulpiride and the anticonvulsant lamotrigine in municipal wastewater treatment plants (WWTPs). Amisulpride, sulpiride and lamotrigine were selected using a tailored non-target screening approach. In WWTPs, lamotrigine concentrations increased from 1.1 to 1.6µg/L while sulpiride and amisulpride exhibited similar concentrations, up to 1.1µg/L and 1.3µg/L, respectively. It was found that N2-glucuronide conjugates of lamotrigine were cleaved to form lamotrigine. Both lamotrigine and amisulpride were detected in groundwater with a concentration of 0.07µg/L. Sulpiride was identified but not quantified. This demonstrates that amisulpride, sulpiride and lamotrigine might be used as indicators for treated wastewater in raw waters used for drinking water production. Furthermore, it could be shown that all three pharmaceutical compounds are efficiently oxidized by ozonation, leading mainly to N-oxide oxidation products. No significant removal of the N-oxides of amisulpride, sulpiride and lamotrigine was observed in the bench-scale biodegradation experiments with activated sludge. This indicated their high biological persistence. Therefore, N-oxides might be appropriate as indicators for post-ozonation as a major technology for the advanced treatment of secondary effluent.


Asunto(s)
Fármacos del Sistema Nervioso Central/aislamiento & purificación , Sulpirida/análogos & derivados , Triazinas/aislamiento & purificación , Contaminantes Químicos del Agua/aislamiento & purificación , Purificación del Agua , Amisulprida , Agua Subterránea/análisis , Lamotrigina , Ozono , Sulpirida/aislamiento & purificación , Aguas Residuales/análisis
3.
Biomed Chromatogr ; 29(12): 1871-7, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26019021

RESUMEN

A novel and efficient sample preconcentration technique based on the Fe3O4 magnetic nanoparticles (Fe3O4 MNPs) coated with silica (SiO2) has been developed for extraction and determination of sulpiride. The functionalized MNPs showed excellent dispersibility in aqueous solution and were applied to magnetic solid-phase extraction of sulpiride from human urine and blood prior to high-performance liquid chromatography analysis. The separation, preconcentration and desorption procedure was completed in 10 min. Optimal experimental conditions, including sample pH, the amount of the MNPs, eluent type and volume, and the ultrasonication time were studied and established. The method showed good linearity for the determination of sulpiride in the concentration range of 10-1000 ng/mL in urine and blood. The recovery of the method was in the range between 91.2 and 97.5%, and the limit of detection was 2 ng/mL for sulpiride in human blood and urine. The results indicated that the present procedure is a suitable pretreatment method for biological samples.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Nanopartículas de Magnetita/química , Extracción en Fase Sólida/métodos , Sulpirida/sangre , Sulpirida/orina , Adulto , Femenino , Humanos , Límite de Detección , Modelos Lineales , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Sulpirida/química , Sulpirida/aislamiento & purificación
4.
J Chromatogr A ; 1380: 177-85, 2015 Feb 06.
Artículo en Inglés | MEDLINE | ID: mdl-25582483

RESUMEN

Quality by design (QbD) concepts, in accordance with International Conference on Harmonisation Pharmaceutical Development guideline Q8(R2), represent an innovative strategy for the development of analytical methods. In this paper QbD principles have been comprehensively applied in the set-up of a capillary electrophoresis method aimed to quantify enantiomeric impurities. The test compound was the chiral drug substance levosulpiride (S-SUL) and the developed method was intended to be used for routine analysis of the pharmaceutical product. The target of analytical QbD approach is to establish a design space (DS) of critical process parameters (CPPs) where the critical quality attributes (CQAs) of the method have been assured to fulfil the desired requirements with a selected probability. QbD can improve the understanding of the enantioseparation process, including both the electrophoretic behavior of enantiomers and their separation, therefore enabling its control. The CQAs were represented by enantioresolution and analysis time. The scouting phase made it possible to select a separation system made by sulfated-ß-cyclodextrin and a neutral cyclodextrin, operating in reverse polarity mode. The type of neutral cyclodextrin was included among other CPPs, both instrumental and related to background electrolyte composition, which were evaluated in a screening phase by an asymmetric screening matrix. Response surface methodology was carried out by a Doehlert design and allowed the contour plots to be drawn, highlighting significant interactions between some of the CPPs. DS was defined by applying Monte-Carlo simulations, and corresponded to the following intervals: sulfated-ß-cyclodextrin concentration, 9-12 mM; methyl-ß-cyclodextrin concentration, 29-38 mM; Britton-Robinson buffer pH, 3.24-3.50; voltage, 12-14 kV. Robustness of the method was examined by a Plackett-Burman matrix and the obtained results, together with system repeatability data, led to define a method control strategy. The method was validated and was finally applied to determine the enantiomeric purity of S-SUL in pharmaceutical dosage forms.


Asunto(s)
Antipsicóticos/aislamiento & purificación , Ciclodextrinas/química , Electroforesis Capilar/métodos , Sulpirida/análogos & derivados , Método de Montecarlo , Estereoisomerismo , Sulpirida/aislamiento & purificación
5.
Se Pu ; 30(12): 1265-70, 2012 Dec.
Artículo en Chino | MEDLINE | ID: mdl-23593884

RESUMEN

A new method of the chiral separation of three drugs such as sulpiride, amisulpride and mosapride was developed on the chiral stationary phase of amylose-tris-(5-chloro-2-methylphenylcarbamate) (ACMPC) by high performance liquid chromatography. The chromatographic behaviors of enantiomers of the three drugs were investigated in the mobile phases consisted of ethanol and n-hexane (containing 0.1% (v/v) diethylamine). The chromatographic conditions including the composition of the mobile phase, additives and temperature were further optimized for the chiral separation. The mechanism of racemic resolution for the mentioned drugs is discussed thermodynamically and structurally. The results indicated that these three chiral drugs could be separated on an ACMPC column under the optimum conditions, and their chiral resolutions were improved up to more than 1.5. The chromatographic parameters such as the retention factor kappa, separation factor a are presented, and the thermodynamic functions were calculated for the separation of the enantiomers of the three drugs. The method has been successfully applied to the determination of the enantiomers of the three drugs in tablets and blood serum. It is simple, reliable and accurate.


Asunto(s)
Antipsicóticos/química , Benzamidas/química , Benzamidas/aislamiento & purificación , Cromatografía Líquida de Alta Presión , Antipsicóticos/aislamiento & purificación , Benzamidas/análisis , Morfolinas/análisis , Morfolinas/química , Morfolinas/aislamiento & purificación , Estereoisomerismo , Sulpirida/análisis , Sulpirida/química , Sulpirida/aislamiento & purificación
6.
Anal Chim Acta ; 583(1): 118-23, 2007 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-17386535

RESUMEN

A simple method using a one-step liquid-liquid extraction (LLE) with butyl acetate followed by high-performance liquid chromatography (HPLC) with positive ion electrospray ionization tandem mass spectrometric (ESI-MS/MS) detection was developed for the determination of itopride in human plasma, using sulpiride as an internal standard (IS). Acquisition was performed in multiple reaction monitoring (MRM) mode, by monitoring the transitions: m/z 359.5>166.1 for itopride and m/z 342.3>111.6 for IS, respectively. Analytes were chromatographed on an YMC C18 reverse-phase chromatographic column by isocratic elution with 1 mM ammonium acetate buffer-methanol (20: 80, v/v; pH 4.0 adjusted with acetic acid). Results were linear (r2=0.9999) over the studied range (0.5-1000 ng mL(-1)) with a total analysis time per run of 2 min for LC-MS/MS. The developed method was validated and successfully applied to bioequivalence studies of itopride hydrochloride in healthy male volunteers.


Asunto(s)
Benzamidas/sangre , Compuestos de Bencilo/sangre , Benzamidas/aislamiento & purificación , Compuestos de Bencilo/aislamiento & purificación , Calibración , Cromatografía Liquida/métodos , Humanos , Indicadores y Reactivos , Espectrometría de Masas/métodos , Soluciones , Solventes , Sulpirida/sangre , Sulpirida/aislamiento & purificación , Equivalencia Terapéutica
7.
Sud Med Ekspert ; 40(3): 28-30, 1997.
Artículo en Ruso | MEDLINE | ID: mdl-9304250

RESUMEN

A method for detecting eglonyl in cadaveric material has been developed. The Stas-Otto method is proposed for isolation. Thin-layer chromatography, spectrophotometry, and high-pressure liquid chromatography can be used for identification and measurements of this substance. The proposed method permits the isolation of up to 55% of the analyzed compound from liver tissue.


Asunto(s)
Antidepresivos de Segunda Generación/análisis , Cadáver , Sulpirida/análisis , Antidepresivos de Segunda Generación/aislamiento & purificación , Cromatografía Líquida de Alta Presión/métodos , Cromatografía en Capa Delgada/métodos , Humanos , Hígado/química , Espectrofotometría Infrarroja/métodos , Espectrofotometría Ultravioleta/métodos , Sulpirida/aislamiento & purificación
8.
J Pharm Sci ; 71(11): 1199-203, 1982 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-7175707

RESUMEN

The major metabolite of sulpiride, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-2-anisamide (I), in the monkey is N-[(1-ethyl-5-oxo-2-pyrrolidinyl)methyl]-5-sulfamoyl-2-anisamide (II). It is also a metabolite in other laboratory animal species and possibly at very low levels in humans. Treatment of the urine from a monkey dosed orally with 14C-I by dry column chromatography and high-pressure liquid chromatography (HPLC) produced the major metabolite in pure form. Characterization of the purified 14C-radiolabeled metabolite by proton NMR, TLC, HPLC, and chemical ionization mass spectroscopy, along with subsequent comparison of a synthetically prepared sample, gave unequivocal structural confirmation.


Asunto(s)
Sulpirida/análogos & derivados , Sulpirida/metabolismo , Animales , Biotransformación , Cromatografía Líquida de Alta Presión , Macaca mulatta , Espectroscopía de Resonancia Magnética , Masculino , Sulpirida/síntesis química , Sulpirida/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA